Abnormalities in Chromosomes 5 and 7 in Myelodysplastic Syndrome and Acute Myeloid Leukemia

被引:0
|
作者
Kendrick, Tulene S. [1 ,2 ,3 ]
Buic, Daria [2 ]
Fuller, Kathy A. [2 ]
Erber, Wendy N. [2 ,3 ]
机构
[1] Royal Perth Hosp, Haematol Dept, Perth, Australia
[2] Univ Western Australia, Sch Biomed Sci, Crawley, Australia
[3] PathWest Lab Med WA, Perth, Australia
关键词
Key Words; Acute myeloid leukemia; Chromosome; 5; 7; Monosomy; Myelo-dysplastic syndrome; THERAPY-RELATED MYELODYSPLASIA; IN-SITU HYBRIDIZATION; COMPLEX KARYOTYPE; MONOSOMAL KARYOTYPE; PROGNOSTIC IMPACT; MICROSATELLITE INSTABILITY; TP53; MUTATIONS; SCORING SYSTEM; DNA-SEQUENCE; NEUTRAL LOSS;
D O I
10.3343/alm.2024.0477
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Chromosomes 5 and 7 are large chromosomes that contain close to 1,000 genes each. Deletions of the long arms or loss of the entire chromosome (monosomy) are common defects in myeloid disorders, particularly MDS and AML. Loss of material from either chromosome 5 or 7 results in haploinsufficiency of multiple genes, with some implicated in leukemogenesis. Abnormalities of one or both occur in up to 15% of MDS and AML cases and co-segregate in half of these. Generally, these chromosomal abnormalities are harbingers of adverse risk in both myeloid disorders. A notable exception is del(5q) in 5q- syndrome, a subtype of MDS. In this review, we describe the pathogenesis and genetic consequences of deletions in chromosomes 5 and 7. Furthermore, we provide an overview of current testing methodologies used in the assessment of these chromosomal defects in hematological malignancies and describe the disease associations and prognostic implications of aberrations in chromosomes 5 and 7 in both MDS and AML.
引用
收藏
页码:133 / 145
页数:13
相关论文
共 50 条
  • [1] Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus:: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7
    Müller, CI
    Engelhardt, M
    Laubenberger, J
    Kunzmann, R
    Engelhardt, R
    Lübbert, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (02) : 115 - 119
  • [2] Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
    Shiseki, Masayuki
    Kitagawa, Yukiko
    Wang, Yan-Hua
    Yoshinaga, Kentaro
    Kondo, Toshiaki
    Kuroiwa, Hanae
    Okada, Michiko
    Mori, Naoki
    Motoji, Toshiko
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2141 - 2144
  • [3] Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 Abnormalities
    Mollgard, Lars
    Nilsson, Lars
    Kjeldsen, Lars
    Dybedal, Ingunn
    Dufva, Inge Hogh
    Garelius, Hege
    Norgaard, Jan Maxwell
    Linder, Olle
    Ejerblad, Elisabeth
    Astermark, Jan
    Hellstrom-Lindberg, Eva
    BLOOD, 2009, 114 (22) : 52 - 52
  • [4] Double minute chromosomes in a patient with myelodysplastic syndrome transforming into acute myeloid leukemia
    Michalová, K
    Cermák, J
    Brezinová, J
    Zemanová, Z
    CANCER GENETICS AND CYTOGENETICS, 1999, 109 (01) : 76 - 78
  • [5] Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome having chromosome 5 and/or 7 abnormalities.
    van der Straaten, HM
    van Biezen, A
    Brand, R
    Schattenberg, AVMB
    Egeler, RM
    Barge, RMY
    Cornelissen, JJ
    Schouten, HC
    Ossenkoppele, GJ
    Verdonck, LF
    BLOOD, 2003, 102 (11) : 603A - 603A
  • [6] Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities
    van der Straaten, Hanneke M.
    van Biezen, Anja
    Brand, Ronald
    Schattenberg, Anton V. M. B.
    Egeler, Roel M.
    Barge, Renee M.
    Cornelissen, Jan J.
    Schouten, Harry C.
    Ossenkoppele, Gert J.
    Verdonck, Leo F.
    HAEMATOLOGICA, 2005, 90 (10) : 1339 - 1345
  • [7] Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype
    Akagi, Tadayuki
    Ogawa, Seishi
    Dugas, Martin
    Kawamata, Norihiko
    Yamamoto, Go
    Nannya, Yasuhito
    Sanada, Masashi
    Miller, Carl W.
    Yung, Amanda
    Schnittger, Susanne
    Haferlach, Torsten
    Haferlach, Claudia
    Koeffler, H. Phillip
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 213 - 223
  • [8] CYTOGENETIC ABNORMALITIES IN CHILDHOOD ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME AND PROGNOSTIC SIGNIFICANCE
    Baka, M.
    Servitzoglou, M.
    Divane, A.
    Pourtsidis, A.
    Bouhoutsou, D.
    Varvoutsi, M.
    Doganis, D.
    Dana, H.
    Panagopoulou, P.
    Kosmidis, H.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 236 - 236
  • [9] Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome
    Pinheiro, R. F.
    Serio, F. M.
    Silva, M. R. R.
    Briones, M. R. S.
    Chauffaille, M. L. L. F.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2008, 41 (07) : 610 - 614
  • [10] Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
    Ravandi, Farhad
    Issa, Jean-Pierre
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Pierce, Sherry
    Shan, Jianqin
    Borthakur, Gautam
    Verstovsek, Srdan
    Faderl, Stefan
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2009, 115 (24) : 5746 - 5751